Imagine microscopic robots, smaller than the width of a human hair, navigating your body, delivering medication precisely to diseased cells.
This futuristic vision is becoming a reality thanks to the groundbreaking research being conducted at the California Institute of Technology (Caltech).

Scientists at Caltech have developed bioresorbable acoustic microrobots (BAMs), tiny spherical robots designed to revolutionize targeted drug delivery. Constructed from a biocompatible hydrogel called poly(ethylene glycol) diacrylate, these BAMs are loaded with therapeutic drugs and magnetic nanoparticles.

The magnetic particles enable precise control of the robots using external magnetic fields, guiding them directly to the targeted site within the body. Once the BAMs reach their destination, the drug passively diffuses out, maximizing treatment efficacy and minimizing side effects.

Creating functional microrobots for medical applications presents numerous challenges, including ensuring they can withstand harsh bodily fluids, are controllable, release their payload only at the target, and are safely absorbed by the body after their task is completed. They also need to navigate the complex environment of biofluids. The Caltech team addressed these challenges with innovative design solutions, including a unique surface modification. The exterior of the BAMs is hydrophilic, attracting water, which prevents them from clumping together. The interior, however, is hydrophobic, repelling water, to trap an air bubble that is crucial for both propulsion and imaging.

This trapped air bubble serves a dual purpose. First, it acts as an excellent ultrasound contrast agent, enabling real-time monitoring of the robots’ movement within the body. Second, it is crucial for the robot’s propulsion. When exposed to an ultrasound field, the bubble vibrates, propelling the BAM forward through streams of fluid expelled from strategically placed openings on the sphere.

The BAMs have demonstrated success in preclinical trials. In studies involving mice with bladder tumors, the microrobots delivered therapeutics more effectively than conventional methods, leading to a substantial reduction in tumor size. The research team believes that this technology holds immense potential for treating a variety of diseases, envisioning its use for delivering a wide range of therapeutic agents, potentially even in humans.

SourceSource.